On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating ...

Q3 2024 Earnings Call Transcript October 15, 2024 Johnson & Johnson beats earnings expectations. Reported EPS is $2.42, ...

Despite a robust increase in sales, Johnson & Johnson (JNJ) faces earnings pressure due to litigation and market headwinds.

Here are eight key developments from spine and orthopedic devicemakers since Oct. 9. 1. Johnson & Johnson MedTech began the ...

The Liberia Petroleum Refining Corporation (LPRC), under its new Managing Director, Amos Tweh, has implemented key measures to revitalize Liberia’s oil and gas sector and alleviate the economic strain ...